Study to Evaluate the Effects of a Cytochrome P450 2C19 Inhibitor on the Pharmacokinetics of Miricorilant

Clinical trial NCT05712265 · COMPLETED

Trial details

NCT number: NCT05712265
Sponsor: Corcept Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Antipsychotic Induced Weight Gain Non-alcoholic Steatohepatitis (NASH)

Start date: 2023-01-24
Primary completion: 2023-02-23
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.